Replies to post #780845 on NorthWest Biotherapeutics Inc (NWBO)

[seekinganswers]

They don't read the full articles or the SEC filings.
They just see a headline from someone else and then pass it along like they actually know something.

[Lykiri]

2025 CNS Annual Meeting.
October 11-15 at the Los Angeles Convention Center.

TUESDAY, OCTOBER 14, 2025

Bench to Bedside: Evolution of Clinical Trials

Moderators:Mahua Dey, Peter E. Fecci
Session Description:This interactive session traces the journey of novel therapies from laboratory discoveries to clinical trials,focusing on the lab discovery, IP generation, IND studies, and transition to clinical trials. Attendees will gain insights into regulatory considerations, funding strategies, ethical challenges,and strategies for improving patient enrollment and retention in neurosurgical-oncology trials from presentations and discussions from the experts.

- DCVax-L for Primary and Recurrent GBM
Linda M. Liau

https://www.cns.org/annualmeeting

[AllSheWrote]

Funny that Dr. Liau would put her name on an article that criticizes the endpoint shift and "an inappropriate selection of external controls." Would love to hear her speak openly one day about what she really thinks of Northwest Biotherapeutics and its management.